263 related articles for article (PubMed ID: 17997974)
21. Serendipitous SAD Solution for DMSO-Soaked SOCS2-ElonginC-ElonginB Crystals Using Covalently Incorporated Dimethylarsenic: Insights into Substrate Receptor Conformational Flexibility in Cullin RING Ligases.
Gadd MS; Bulatov E; Ciulli A
PLoS One; 2015; 10(6):e0131218. PubMed ID: 26121586
[TBL] [Abstract][Full Text] [Related]
22. Distinct activities of suppressor of cytokine signaling (SOCS) proteins and involvement of the SOCS box in controlling G-CSF signaling.
van de Geijn GJ; Gits J; Touw IP
J Leukoc Biol; 2004 Jul; 76(1):237-44. PubMed ID: 15107455
[TBL] [Abstract][Full Text] [Related]
23. Both the suppressor of cytokine signaling 1 (SOCS-1) kinase inhibitory region and SOCS-1 mimetic bind to JAK2 autophosphorylation site: implications for the development of a SOCS-1 antagonist.
Waiboci LW; Ahmed CM; Mujtaba MG; Flowers LO; Martin JP; Haider MI; Johnson HM
J Immunol; 2007 Apr; 178(8):5058-68. PubMed ID: 17404288
[TBL] [Abstract][Full Text] [Related]
24. A three-dimensional model of Suppressor Of Cytokine Signalling 1 (SOCS-1).
Giordanetto F; Kroemer RT
Protein Eng; 2003 Feb; 16(2):115-24. PubMed ID: 12676980
[TBL] [Abstract][Full Text] [Related]
25. Elongin B/C recruitment regulates substrate binding by CIS.
Piessevaux J; De Ceuninck L; Catteeuw D; Peelman F; Tavernier J
J Biol Chem; 2008 Aug; 283(31):21334-46. PubMed ID: 18508766
[TBL] [Abstract][Full Text] [Related]
26. Tyrosine phosphorylation disrupts elongin interaction and accelerates SOCS3 degradation.
Haan S; Ferguson P; Sommer U; Hiremath M; McVicar DW; Heinrich PC; Johnston JA; Cacalano NA
J Biol Chem; 2003 Aug; 278(34):31972-9. PubMed ID: 12783885
[TBL] [Abstract][Full Text] [Related]
27. Crystal structure of Human ASB9-2 and substrate-recognition of CKB.
Fei X; Gu X; Fan S; Yang Z; Li F; Zhang C; Gong W; Mao Y; Ji C
Protein J; 2012 Apr; 31(4):275-84. PubMed ID: 22418839
[TBL] [Abstract][Full Text] [Related]
28. Structural insights into substrate recognition by the SOCS2 E3 ubiquitin ligase.
Kung WW; Ramachandran S; Makukhin N; Bruno E; Ciulli A
Nat Commun; 2019 Jun; 10(1):2534. PubMed ID: 31182716
[TBL] [Abstract][Full Text] [Related]
29. Structural basis for c-KIT inhibition by the suppressor of cytokine signaling 6 (SOCS6) ubiquitin ligase.
Zadjali F; Pike AC; Vesterlund M; Sun J; Wu C; Li SS; Rönnstrand L; Knapp S; Bullock AN; Flores-Morales A
J Biol Chem; 2011 Jan; 286(1):480-90. PubMed ID: 21030588
[TBL] [Abstract][Full Text] [Related]
30. The SOCS2 ubiquitin ligase complex regulates growth hormone receptor levels.
Vesterlund M; Zadjali F; Persson T; Nielsen ML; Kessler BM; Norstedt G; Flores-Morales A
PLoS One; 2011; 6(9):e25358. PubMed ID: 21980433
[TBL] [Abstract][Full Text] [Related]
31. The SOCS box encodes a hierarchy of affinities for Cullin5: implications for ubiquitin ligase formation and cytokine signalling suppression.
Babon JJ; Sabo JK; Zhang JG; Nicola NA; Norton RS
J Mol Biol; 2009 Mar; 387(1):162-74. PubMed ID: 19385048
[TBL] [Abstract][Full Text] [Related]
32. Role of the cytokine-inducible SH2 protein CIS in desensitization of STAT5b signaling by continuous growth hormone.
Ram PA; Waxman DJ
J Biol Chem; 2000 Dec; 275(50):39487-96. PubMed ID: 10991939
[TBL] [Abstract][Full Text] [Related]
33. The SOCS-box of HIV-1 Vif interacts with ElonginBC by induced-folding to recruit its Cul5-containing ubiquitin ligase complex.
Bergeron JR; Huthoff H; Veselkov DA; Beavil RL; Simpson PJ; Matthews SJ; Malim MH; Sanderson MR
PLoS Pathog; 2010 Jun; 6(6):e1000925. PubMed ID: 20532212
[TBL] [Abstract][Full Text] [Related]
34. VHL-box and SOCS-box domains determine binding specificity for Cul2-Rbx1 and Cul5-Rbx2 modules of ubiquitin ligases.
Kamura T; Maenaka K; Kotoshiba S; Matsumoto M; Kohda D; Conaway RC; Conaway JW; Nakayama KI
Genes Dev; 2004 Dec; 18(24):3055-65. PubMed ID: 15601820
[TBL] [Abstract][Full Text] [Related]
35. Differential roles of SOCS family members in EpoR signal transduction.
Jegalian AG; Wu H
J Interferon Cytokine Res; 2002 Aug; 22(8):853-60. PubMed ID: 12396724
[TBL] [Abstract][Full Text] [Related]
36. Insights into the Evolution of the Suppressors of Cytokine Signaling (SOCS) Gene Family in Vertebrates.
Wang B; Wangkahart E; Secombes CJ; Wang T
Mol Biol Evol; 2019 Feb; 36(2):393-411. PubMed ID: 30521052
[TBL] [Abstract][Full Text] [Related]
37. Expression of SOCS1-7 and CIS mRNA in porcine tissues.
Delgado-Ortega M; Melo S; Meurens F
Vet Immunol Immunopathol; 2011 Dec; 144(3-4):493-8. PubMed ID: 21872343
[TBL] [Abstract][Full Text] [Related]
38. Optimization of Phosphotyrosine Peptides that Target the SH2 Domain of SOCS1 and Block Substrate Ubiquitination.
Chen H; Wu Y; Li K; Currie I; Keating N; Dehkhoda F; Grohmann C; Babon JJ; Nicholson SE; Sleebs BE
ACS Chem Biol; 2022 Feb; 17(2):449-462. PubMed ID: 34989544
[TBL] [Abstract][Full Text] [Related]
39. Epigenetic modification of SOCS-1 differentially regulates STAT3 activation in response to interleukin-6 receptor and epidermal growth factor receptor signaling through JAK and/or MEK in head and neck squamous cell carcinomas.
Lee TL; Yeh J; Van Waes C; Chen Z
Mol Cancer Ther; 2006 Jan; 5(1):8-19. PubMed ID: 16432158
[TBL] [Abstract][Full Text] [Related]
40. Suppressors of cytokine signalling (SOCS) are reduced in osteoarthritis.
de Andrés MC; Imagawa K; Hashimoto K; Gonzalez A; Goldring MB; Roach HI; Oreffo RO
Biochem Biophys Res Commun; 2011 Apr; 407(1):54-9. PubMed ID: 21352802
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
